Table II.
CT-1 serum concentrations according to the metabolic or vascular diagnosis of interest
| Variable | CT-1 concentrations [ng/ml] | Value of p | |
|---|---|---|---|
| Yes | No | ||
| Obesity (BMI ≥ 30 kg/m2) | 1.18 (0.64–1.64) | 1.56 (1.37–2.04) | 0.013 |
| Elevated WC (> 102 cm in men and > 88 cm in women) | 1.43 (0.94–1.60) | 1.64 (1.39–2.49) | 0.047 |
| Diabetes | 1.45 (1.25–1.77) | 1.60 (1.30–2.02) | 0.870 |
| Hypertension | 1.64 (1.35–3.41) | 1.49 (1.23–1.72) | 0.187 |
| Hypo-HDL (< 40 mg/dl in men or < 50 mg/dl in women) | 1.41 (0.98–1.54) | 1.65 (1.37–2.34) | 0.069 |
| Hypertriglyceridemia (> 150 mg/dl or treated) | 1.48 (1.33–1.65) | 1.60 (1.23–2.40) | 0.516 |
| Metabolic syndrome | 1.55 (1.21–2.01) | 1.47 (1.35–1.92) | 0.78 |
| Intima-media thickness, > 1.1 mm | 1.56 (1.33–2.50) | 1.45 (1.15–1.77) | 0.270 |
| Carotid artery disease, presence of plaques | 1.48 (1.02–2.40) | 1.51 (1.35–1.72) | 0.996 |
| Coronary artery disease, mono or multivessel | 1.55 (1.33–1.92) | 1.46 (1.23–2.02) | 0.737 |